The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma
Open accessAbstract
Uterine leiomyomata (ULs) represent the most common tumor in women and can cause abnormal uterine bleeding, large pelvic masses, and recurrent pregnancy loss. Although the dependency of UL growth on ovarian steroids is well established, the relative contributions of 17β-estradiol and progesterone are yet to be clarified. Conventionally, estradiol has been considered the primary stimulus for UL growth, and studies with cell culture and animal models support this concept. In contrast, no research model has clearly demonstrated a requirement of progesterone in UL growth despite accumulating clinical evidence for the essential role of progesterone in this tumor. To elucidate the functions of ovarian steroids in UL, we established a xenograft model reflecting characteristics of these tumors by grafting human UL tissue beneath the renal capsule of immunodeficient mice. Leiomyoma xenografts increased in size in response to estradiol plus progesterone through cell proliferation and volume increase in cellular and extracellular components. The xenograft growth induced by estradiol plus progesterone was blocked by the antiprogestin RU486. Furthermore, the volume of established UL xenografts decreased significantly after progesterone withdrawal. Surprisingly, treatment with estradiol alone neither increased nor maintained the tumor size. Although not mitogenic by itself, estradiol induced expression of progesterone receptor and supported progesterone action on leiomyoma xenografts. Taken together, our findings define that volume maintenance and growth of human UL are progesterone dependent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taking Cell-Matrix Adhesions to the Third Dimension
Cukierman, E., Pankov, R., Stevens, D. R., & Yamada, K. M. (2001) · Science · doi:10.1126/science.1064829 · Cited by 3,027
High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence
Day Baird, D., Dunson, D. B., Hill, M. C., Cousins, D., & Schectman, J. M. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.99 · Cited by 2,435
Transmembrane crosstalk between the extracellular matrix and the cytoskeleton
Geiger, B., Bershadsky, A., Pankov, R., & Yamada, K. M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35099066 · Cited by 2,209
Shultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S. D., King, M., Mangada, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6477 · Cited by 1,728
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Etiology, symptomatology, and diagnosis of uterine myomas
Parker, W. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.01.093 · Cited by 721
Bebo, B. F., Fyfe-Johnson, A., Adlard, K., Beam, A. G., Vandenbark, A. A., & Offner, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.3.2080 · Cited by 341
Marshall, L. M., Spiegelman, D., Goldman, M. B., Manson, J. E., Colditz, G. A., Barbieri, R. L., Stampfer, M. J., & Hunter, D. J. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00208-8 · Cited by 330
Hysterectomy surveillance in the United States, 1997 through 2005.
Merrill, R. M. (2008) · PubMed · Cited by 296
Sex steroidal regulation of uterine leiomyoma growth and apoptosis
Maruo, T. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh019 · Cited by 294
Mitotic activity in uterine leiomyomas during the menstrual cycle
Kawaguchi, K., Fujii, S., Konishi, I., Nanbu, Y., Nonogaki, H., & Mori, T. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(89)80046-8 · Cited by 240
Why is Parity Protective for Uterine Fibroids?
Day Baird, D., & Dunson, D. B. (2003) · Epidemiology · doi:10.1097/01.ede.0000054360.61254.27 · Cited by 195
Fiscella, K., Eisinger, S. H., Meldrum, S., Feng, C., Fisher, S. G., & Guzick, D. S. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000243776.23391.7b · Cited by 193
Ishibashi, H., Suzuki, T., Suzuki, S., Niikawa, H., Lu, L., Miki, Y., Moriya, T., Hayashi, S.-I., Handa, M., Kondo, T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3087 · Cited by 177
Reproductive Factors and Risk of Uterine Fibroids
Parazzini, F., Negri, E., La Vecchia, C., Chatenoud, L., Ricci, E., & Guarnerio, P. (1996) · Epidemiology · doi:10.1097/00001648-199607000-00018 · Cited by 171
Longitudinal evaluation of uterine myoma growth during pregnancy. A sonographic study
Rosati, P., Exacoustòs, C., & Mancuso, S. (1992) · Journal of Ultrasound in Medicine · doi:10.7863/jum.1992.11.10.511 · Cited by 171
Matsuo, H., Maruo, T., & Samoto, T. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.1.3650 · Cited by 159
Stewart, E. A., Friedman, A. J., Peck, K., & Nowak, R. A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.3.8077380 · Cited by 157
Sumitani, H., Shozu, M., Segawa, T., Murakami, K., Yang, H.-J., Shimada, K., & Inoue, M. (2000) · Endocrinology · doi:10.1210/endo.141.10.7719 · Cited by 155
Shimomura, Y., Matsuo, H., Samoto, T., & Maruo, T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4879 · Cited by 151
Hodgkin disease survivors at increased risk for problems in psychosocial adaptation
Kornblifh, A. B., Anderson, J. R., Cella, D. F., Tross, S., Zuckerman, E., Cherin, E., Henderson, E. S., Weiss, R. B., Cooper, M. R., Silver, R. T., et al. (1992) · Cancer · doi:10.1002/1097-0142(19921015)70:8<2051::aid-cncr2820700806>3.0.co;2-1 · Cited by 148
Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse
Gross, G. A., Imamura, T., Vogt, S. K., Wozniak, D. F., Nelson, D. M., Sadovsky, Y., & Muglia, L. J. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.6.r1415 · Cited by 146
Shunting the intervillous space: new concepts in human uteroplacental vascularization
Schaaps, J.-P., Tsatsaris, V., Goffin, F., Brichant, J.-F., Delbecque, K., Tebache, M., Collignon, L., Retz, M. C., & Foidart, J.-M. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.066 · Cited by 142
Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas
Eisinger, S. H., Bonfiglio, T. A., Fiscella, K. A., Meldrum, S. C., & Guzick, D. S. (2005) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2005.01.022 · Cited by 140
The Effect of Progestins on the Mitotic Activity of Uterine Fibromyomas
Tiltman, A. J. (1985) · International Journal of Gynecological Pathology · doi:10.1097/00004347-198506000-00001 · Cited by 134
Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial
Engman, M., Granberg, S., Williams, A. R. W., Meng, C., Lalitkumar, P. G., & Gemzell‐Danielsson, K. (2009) · Human Reproduction · doi:10.1093/humrep/dep100 · Cited by 133
Risk Factors for Uterine Fibroids among Women Undergoing Tubal Sterilization
Chen, C.-R., Louis, G. M. B., Courey, N. G., Perez, K. M., & Wactawski‐Wende, J. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.1.20 · Cited by 131
Williams, A. R. W., Critchley, H., Osei, J., Ingamells, S., Cameron, I. T., Han, C., & Chwalisż, K. (2007) · Human Reproduction · doi:10.1093/humrep/dem026 · Cited by 122
Wang, Y., Xue, H., Cutz, J., Bayani, J., Mawji, N. R., Chen, W. G., Goetz, L., Hayward, S. W., Sadar, M. D., Gilks, C. B., et al. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700335 · Cited by 118
Kurita, T., Lee, K.-J., Saunders, P. T. K., Cooke, P. S., Taylor, J. A., Lubahn, D. B., Zhao, C., Mäkelä, S., Gustafsson, J., Dahiya, R., et al. (2001) · Biology of Reproduction · doi:10.1095/biolreprod64.1.272 · Cited by 115
Self-citationEstrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo
Howe, S. R., Gottardis, M. M., Everitt, J. I., & Walker, C. L. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588234 · Cited by 114
Wilkens, J., Chwalisż, K., Han, C., Walker, J., Cameron, I. T., Ingamells, S., Lawrence, A. C., Lumsden, M. A., Hapangama, D. K., Williams, A. R. W., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1104 · Cited by 105
Matsuo, H. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.293 · Cited by 98
Yin, P., Lin, Z., Cheng, Y.-H., Marsh, E. E., Utsunomiya, H., Ishikawa, H., Xue, Q., Reierstad, S., Innes, J. E., Thung, S., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0725 · Cited by 96
Self-citationMifepristone for the Treatment of Uterine Leiomyomas: A Randomized Controlled Trial
Esteve, J. L. C., Acosta, R., Heredia, B., Pérez, Y., Castañeda, M. C. Y., & Hernández, A. V. (2008) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31818aa930 · Cited by 94
Zaitseva, M., Vollenhoven, B. J., & Rogers, P. A. W. (2006) · Molecular Human Reproduction · doi:10.1093/molehr/gal018 · Cited by 94
Chen, W., Ohara, N., Wang, J., Xu, Q., Liu, J., Morikawa, A., Sasaki, H., Yoshida, S., DeManno, D. A., Chwalisż, K., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2379 · Cited by 92
Andersen, J., DyReyes, V. M., Barbieri, R. L., Coachman, D. M., & Miksicek, R. J. (1995) · Journal of the Society for Gynecologic Investigation · doi:10.1016/1071-5576(94)00053-4 · Cited by 90
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas
Deng, L., Wu, T., Chen, X. Y., Xie, L., & Yang, J. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005287.pub4 · Cited by 88
Pregnancy-related changes in the size of uterine leiomyomas.
Neiger, R., Sonek, J., Croom, C. S., & Ventolini, G. (2006) · PubMed · Cited by 86
Burroughs, K. D., Fuchs‐Young, R., Davis, B. J., & Walker, C. L. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.5.1322 · Cited by 77
Di, X., Yu, L. C., Moore, A. B., Castro, L., Zheng, X., Hermon, T., & Dixon, D. (2008) · Human Reproduction · doi:10.1093/humrep/den087 · Cited by 72
Volume change of uterine myomas during pregnancy: Do myomas really grow?
Hammoud, A. O., Asaad, R., Berman, J. M., Treadwell, M. C., Blackwell, S. C., & Diamond, M. P. (2006) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2006.04.003 · Cited by 70
Kurita, T., Medina, R. T., Schabel, A. B., Young, P., Gama, P., Parekh, T. V., Brody, J. R., Cunha, G. R., Osteen, K. G., Bruner‐Tran, K. L., et al. (2005) · Differentiation · doi:10.1111/j.1432-0436.2005.00033.x · Cited by 66
Self-citationShimomura, Y. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2192 · Cited by 57
Proliferative Activity of Human Uterine Leiomyoma Cells as Measured by Automatic Image Analysis
Lamminen, S., Rantald, I., Helin, H., Rorarius, M. G. F., & Tuimala, R. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000292738 · Cited by 52
Protective effect of pregnancy for development of uterine leiomyoma
Walker, C. L., Cesen-Cummings, K., Houle, C. D., Baird, D. D., Barrett, J. C., & Davis, B. J. (2001) · Carcinogenesis · doi:10.1093/carcin/22.12.2049 · Cited by 51
Lipschütz, A., & Vargas, L. A. (1941) · Cancer Research · Cited by 49
Yamada, T. (2004) · Human Reproduction · doi:10.1093/humrep/deh146 · Cited by 49
Donnez, J., Vivancos, B. H., Kudela, M., Audebert, A. J. M., & Jadoul, P. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(03)00261-9 · Cited by 46
Hassan, M. H., Eyzaguirre, E. J., Arafa, H. M. M., Hamada, F. M. A., Salama, S. A., & Al-Hendy, A. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.02.010 · Cited by 46
Endocrinology and paracrinology
Severino, M. F., Murray, M. J., Brandon, D. D., Clinton, G. M., Burry, K. A., & Novy, M. J. (1996) · Molecular Human Reproduction · doi:10.1093/molehr/2.11.823 · Cited by 44
Park, S., Ramachandran, S., Kwon, S., Cha, S.-D., Seo, E. W., Bae, I., Cho, C., & Song, D. (2008) · Gynecological Endocrinology · doi:10.1080/09513590801893315 · Cited by 24
Effects of progesterone on ovarian tumorigenesis in xenografted mice
McDonnel, A. C., Kirk, E. A. V., Isaak, D. D., & Murdoch, W. J. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.09.011 · Cited by 22
Cited by
State-of-the-science of endocrine disrupting chemicals, 2012
Bergman, Å., Heindel, J., Jobling, S., Kidd, K., & Zoeller, R. T. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.020 · Cited by 1,388
Bulun, S. E. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1209993 · Cited by 703
Self-citationStewart, E. A., Laughlin-Tommaso, S. K., Catherino, W. H., Lalitkumar, S., Gupta, D., & Vollenhoven, B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.43 · Cited by 531
Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Self-citationMenstruation: science and society
Critchley, H. O. D., Babayev, E., Bulun, S. E., Clark, S., Garcia-Grau, I., Gregersen, P. K., Kilcoyne, A., Kim, J.-Y. J., Lavender, M., Marsh, E. E., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.06.004 · Cited by 448
Self-citation
Metadata
- Authors
- Ishikawa, H., Ishi, K., Serna, V. A., Kakazu, R., Bulun, S. E., & Kurita, T.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2010-04-07
- Volume
- 151
- Issue
- 6
- Pages
- 2433-2442
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2026448022
- Cited by
- 362
- References
- 54
- FWCI
- 17.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.